Up to three acquisitions are "in the pipeline" for Euclidian, a source said.
Euclidian was due to float on the Alternative Investment Market (AIM) yesterday at its expected value of £125m. The expected flotation price offered to investors was £1 per share.
Warren Buffett's Berkshire Hathaway has taken a £31.25m share , equivalent to 25% of the company. All shares would be fully-traded shares, a source said.
